Teva to donate over $15 bln worth of drugs in opioid settlement: Source
Teva has offered to give away generic drugs, including those that help fight opioid overdose, to resolve all of its cases in an agreement that would run over 10 years
Teva Pharmaceuticals is in talks to contribute over $15 billion worth of drugs as part of a settlement to resolve lawsuits alleging it helped fuel the US opioid crisis, a source familiar with the matter told Reuters.
The news follows media reports that major drug distributors McKesson, AmerisourceBergen and Cardinal Health are discussing with governments to settle thousands of opioid-related lawsuits for $18 billion.
The companies, including Teva, are all defendants in a landmark trial set to begin in federal court in Cleveland, Ohio, on October 21, which will be presided over by US District Judge Dan Polster, who has long pushed for a global settlement of the litigation.
The source also said Johnson & Johnson had offered to pay $4 billion to settle claims related to the US opioid epidemic.
Teva has offered to give away generic drugs, including those that help fight opioid overdose, to resolve all of its cases in an agreement that would run over 10 years, Bloomberg reported.
Teva did not immediately respond to Reuters’ request for comment. If the distributors and Teva settle before the start of the trial, the remaining defendants would be Walgreens Boots Alliance and Henry Schein.